obesity drug news today october 2025 glp-1 The FDA approved a pill version of the receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 Obesity GLP-1 Market Size to

Documented starting doses begin around 300 mcg once daily (morning fasted or before bed 3+ hours after last meal) during weeks 1-2 to assess tolerance, then optionally progress to twice daily for enhanced GH elevation

Glutathione is a tripeptide entity commonly described in biochemical literature through glutamate, cysteine, and glycine structure context [3]

We are thrilled to have the support of a syndicate that truly believes in our vision to transform orthodontics, said KLOwen Orthodontics CEO, Ryan Elmore

It helps reduce dark spots, pigmentation, and uneven skin tone by inhibiting melanin synthesis

ClinicalTrials.gov has registered more than 100 IC/BPS-related studies, generating clinical evidence that supports regulatory progress, improved treatment strategies, and future therapeutic innovation